ARCHIVES

NCAB Approves Year 2000 Report; Implementation Depends On Adequate Funding Starting With FY 1986

This article is from The Cancer Letter archive.

Vol. 11 No. 28 | July 12, 1985

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014